Jim Cramer - Mad MoneyARS PharmaceuticalsSPRYBUYJun 11, 2025

He likes their model, and there is no demand for their products.

Jim Cramer - Mad Money

Unknown

Unlock Rating

$14.36

Stock price when the opinion was issued

$4.48

As of Sep 22, 2026. Market Open.

Pharma & Healthcare

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

RISKY

Speculative, but we need more pharma companies to make immunotherapy drugs.

Most Recent Experts

Ernest Wong, Head of Research, Baskin Wealth Management

Baskin Wealth Management

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Joe Terranova

Virtus Investment Partners

Stephanie Link, Chief investment strategist, Hightower

Hightower

Jim Lebenthal

Cerity Partners

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Jim Cramer - Mad MoneyARS PharmaceuticalsSPRYBUYJun 11, 2025

You might be interested:

ARS Pharmaceuticals(SPRY)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals